TY  - JOUR

T1  - Baricitinib for previously treated moderate or severe rheumatoid arthritis: an evidence review group perspective of a NICE single technology appraisal


JO  - PharmacoEconomics

UR  - https://eprints.whiterose.ac.uk/id/eprint/126812

PY  - 2018/07/01

AU  - Ren S

AU  - Bermejo I

AU  - Simpson E

AU  - Wong R

AU  - Scott D

AU  - Young A

AU  - Stevenson M

ED  - 

DO  - DOI: 10.1007/s40273-018-0616-7

PB  - Adis

VL  - 36

SP  - 769

EP  - 778

Y2  - 2024/12/22

ER  -